You are here: Industry Insights > Pfizer

News List

Australia purchases Pfizer vaccines from Poland as COVID-19 infections spike firstwordpharma
August 16, 2021
Australia has bought about 1 million doses of Pfizer's COVID-19 vaccine from Poland to bolster its inoculation efforts in Sydney and its home state of New South Wales, as reported in Investing.com.
Moderna Vaccine May Shield More Against Breakthrough Infections Than Pfizer: Study drugs
August 13, 2021
People fully vaccinated with the Moderna COVID-19 vaccine appear to have a lower risk for a "breakthrough" infection caused by the delta variant than those who received the Pfizer vaccine, a new, preliminary report suggests.
Pfizer Shot May Help Fight COVID Variants in People Previously Infected drugs
August 12, 2021
A small, early study suggests that people who've already encountered SARS-CoV-2 may gain a big boost against COVID-19 if they get just one dose of the Pfizer vaccine — and that protection may extend to new viral variants.
BioNTech says repeats of its COVID-19 vaccine better than devising new one, for now expresspharma
August 11, 2021
The German biotech firm said that offering a third dose of its established two-shot vaccine remained the best response to concerns over waning immune protection in the face of the highly contagious Delta variant, as worse strains may emerge.
BioNTech’s 2Q Revenue Soars contractpharma
August 10, 2021
Growth due to rapid increases in the supply of BNT162b2 as BioNTech and Pfizer evaluate a third dose to boost efficacy against Delta variant.
Pfizer, Flynn accused of charging the NHS 'unfairly high prices' for anti-epilepsy drug pharmatimes
August 09, 2021
Pfizer and Flynn have been accused of breaking competition law by overcharging the NHS for ‘vital’ anti-epilepsy drugs, according to provisional findings from the UK Competition and Markets Authority (CMA).
Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd firstwordpharma
August 09, 2021
According to an initial survey in Israel, most people who received a third dose of Pfizer's COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second dose, as reported Fidelity on Sunday.
Ritlecitinib improves scalp hair regrowth in alopecia trial europeanpharmaceuticalreview
August 06, 2021
Ritlecitinib was shown to reduce scalp hair loss to less than or equal to 20 percent after six months in Pfizer’s Phase IIb/III trial.
Gov’t launches study on COVID-19 vaccine dose interval for pregnant women pharmatimes
August 06, 2021
A new clinical trial investigating the optimal gap between first and second COVID-19 vaccine doses for pregnant women is set to launch in England 3rd.
16- and 17-year-olds should receive first COVID-19 vaccine, advises JCVI pharmatimes
August 06, 2021
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all 16 and 17 year olds receive their first dose of the Pfizer-BioNTech vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page